This legislation, titled the "Cutting Copays Act," aims to significantly reduce out-of-pocket prescription drug costs for low-income individuals enrolled in Medicare Part D . It achieves this by amending the Social Security Act to adjust cost-sharing reductions for eligible beneficiaries. A key provision establishes a $0 copayment for generic drugs for these individuals, effective for plan year 2026. For other non-generic drugs, the copayment amount will be set at the 2023 level for plan year 2026. In subsequent years, the copayment for these non-generic drugs will be adjusted annually based on the Consumer Price Index . These changes are designed to make essential medications more affordable and accessible for vulnerable Medicare beneficiaries.